Ignite Creation Date:
2025-12-25 @ 2:35 AM
Ignite Modification Date:
2025-12-31 @ 12:27 PM
Study NCT ID:
NCT05752734
Status:
COMPLETED
Last Update Posted:
2023-09-21
First Post:
2023-02-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Preoperative Dexamethasone to Improve Quality of Recovery After Laparoscopic Bariatric Surgery
Sponsor:
Ondokuz Mayıs University
Organization:
Study Overview
Official Title:
Preoperative Dexamethasone Enhances Quality of Recovery After Laparoscopic Bariatric Surgery: A Prospective Observational Study
Status:
COMPLETED
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In the obese patient, adequate pain relief in the postoperative period is an important parameter that affects patient comfort and hospital stay. Increasing patient comfort and recovery quality can be achieved by avoiding undesirable effects such as nausea and vomiting, as well as analgesia. In our study, our aim is to evaluate the effect of dexamethasone added to multimodal analgesia on postoperative patient comfort in the obese patient group with a 40-item scale.
Detailed Description:
Postoperative pain prolongs hospital stay, delays wound healing, increases infection rates, and increases the incidence of drug side effects due to the use of systemic pain relievers (especially opioids).
Good pain control facilitates respiratory effort, allows the patient to perform respiratory exercises and cough to correct the increased thoracic fat mass and impaired respiratory mechanics due to anesthesia. The patient without pain is mobilized early and discharged early.
Our aim is to evaluate the effect of dexamethasone added to multimodal analgesia on postoperative patient comfort in the obese patient group with a 40-item scale.
Patients will be divided in to two groups (group D and group C):
Group D (Dexamethasone Group):
Patients who used/applied dexamethasone before bariatric surgery were included in this group.
Group C(Control Group):
Patients who did not use dexamethasone or steroid-derived drugs were included in this group.
The patients included in the study were evaluated with the 40-item recovery quality scale (QoR-40) 24 hours after the operation.
İn addition all patients will be administered iv morphine pca (patient controlled analgesia) for the first 24 hours postoperatively
Good pain control facilitates respiratory effort, allows the patient to perform respiratory exercises and cough to correct the increased thoracic fat mass and impaired respiratory mechanics due to anesthesia. The patient without pain is mobilized early and discharged early.
Our aim is to evaluate the effect of dexamethasone added to multimodal analgesia on postoperative patient comfort in the obese patient group with a 40-item scale.
Patients will be divided in to two groups (group D and group C):
Group D (Dexamethasone Group):
Patients who used/applied dexamethasone before bariatric surgery were included in this group.
Group C(Control Group):
Patients who did not use dexamethasone or steroid-derived drugs were included in this group.
The patients included in the study were evaluated with the 40-item recovery quality scale (QoR-40) 24 hours after the operation.
İn addition all patients will be administered iv morphine pca (patient controlled analgesia) for the first 24 hours postoperatively
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: